HBOT for migraine and cluster headache: what the evidence actually shows
Weak, low-quality evidence suggests hyperbaric oxygen may ease some acute migraines but not prevent them. For cluster headache, ordinary high-flow oxygen has the stronger case.
What the Cochrane review actually examined
When people ask whether a pressurised chamber can settle a severe migraine or a cluster attack, the most frequently cited source is a Cochrane systematic review by Michael Bennett and colleagues, "Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache." First published in 2008 and updated in 2015, it pooled 11 small randomised trials with roughly 209 participants in total.
The reviewers kept two questions apart: whether oxygen can stop an attack already underway, and whether it can prevent future attacks. They also separated two very different treatments - hyperbaric oxygen (HBOT), breathed under increased pressure inside a chamber, and normobaric oxygen (NBO), breathed at ordinary room pressure through a mask. Those distinctions matter, because the answers are not the same.
Migraine: a faint signal, from small studies only
For acute migraine, the review reported some evidence that HBOT relieved pain compared with sham treatment, drawn mainly from a small pool of trials. The authors were careful to grade that signal as low-quality evidence: several studies were tiny, incompletely reported, or available only as conference abstracts, which limits how much weight it can carry.
Just as important, the reviewers found no evidence that HBOT prevents future migraine attacks, so it is not a preventive tool. Taken together, this falls well short of establishing HBOT as a routine migraine treatment. Most attacks respond to established drug options, and the review itself noted that more research is needed to work out which patients, if any, might benefit. Confident clinic promises about migraine and hyperbaric oxygen should be weighed against this cautious picture.
Cluster headache: normobaric oxygen has the better case
Cluster headache is where the difference between the two therapies becomes decisive. Here the better-supported acute option is normobaric oxygen, not hyperbaric. Breathing high-flow 100% oxygen through a non-rebreather mask at room pressure is endorsed as a first-line acute treatment by bodies including the American Headache Society, and randomised data show it can bring relief or freedom from an attack within about 15 minutes in a large share of patients.
Hyperbaric oxygen, by contrast, rests on much thinner evidence for cluster headache; the Cochrane review described only weak, uncertain support, and neither form of oxygen showed a preventive effect. In practice this means the widely used answer for cluster attacks is a standard oxygen cylinder and mask - a treatment quite separate from pressurised chamber sessions.
Reading these findings in context
A few practical points follow. The safety record across the trials was reassuring: no serious adverse events were reported during HBOT or NBO. Hyperbaric treatment still carries its own well-known precautions around pressure, and people with certain lung conditions need medical screening before any oxygen therapy. Cost and access differ sharply too, since a mask-and-cylinder setup for cluster headache is modest while chamber sessions are far more involved.
For readers who are comparing hyperbaric equipment for other reasons, our manufacturer overview at manufacturer directory sets out how different chamber types and pressure ratings compare, which is useful context before spending on any device.
The honest summary is narrow: a weak, low-quality signal that HBOT may help some acute migraines, no evidence it prevents them, and, for cluster headache, a far stronger case for ordinary high-flow oxygen than for a pressure chamber. None of this is a recommendation. If you live with migraine or cluster headache, talk it through with a doctor who knows your history before acting on anything you have read here.
- Cochrane - Oxygen therapy for migraine and cluster headache (Bennett, 2015)
- Cochrane - Plain-language summary (CD005219)
- American Headache Society - Joint statement on oxygen therapy for cluster headache
- American Migraine Foundation - Joint statement on oxygen therapy
- Cochrane review full text (PMC8720466)